NASDAQ:JAGX - Jaguar Health News Headlines

Sign in or create an account to add this stock to your watchlist.
$0.2390 0.00 (0.00 %)
(As of 02/18/2019 04:00 PM ET)
Previous Close$0.24
Today's Range$0.23 - $0.24
52-Week Range$0.12 - $6.60
Volume379,114 shs
Average Volume459,763 shs
Market Capitalization$15.51 million
P/E RatioN/A
Dividend YieldN/A
Beta1.18

Headlines

Jaguar Health (NASDAQ JAGX) News Headlines

Source:
DateHeadline
Jaguar Health (JAGX) & Zosano Pharma (ZSAN) Critical ReviewJaguar Health (JAGX) & Zosano Pharma (ZSAN) Critical Review
www.americanbankingnews.com - February 5 at 1:18 PM
Form 8-K Jaguar Health, Inc. For: Jan 28 - StreetInsider.comForm 8-K Jaguar Health, Inc. For: Jan 28 - StreetInsider.com
www.streetinsider.com - January 30 at 6:57 PM
With the Addition of Mytesi to the Formulary for Floridas AIDS Drug Assistance Program (ADAP), Approximately 86% of ADAP-Eligible US Lives Now Have Access to Jaguar Healths FDA-Approved Drug ProductWith the Addition of Mytesi to the Formulary for Florida's AIDS Drug Assistance Program (ADAP), Approximately 86% of ADAP-Eligible US Lives Now Have Access to Jaguar Health's FDA-Approved Drug Product
finance.yahoo.com - January 24 at 6:28 PM
Jaguar Health to Present at Noble Capital Markets Annual Investor Conference January 28 in Fort LauderdaleJaguar Health to Present at Noble Capital Markets Annual Investor Conference January 28 in Fort Lauderdale
finance.yahoo.com - January 22 at 6:18 PM
Form SC 13G/A Jaguar Health, Inc. Filed by: SABBY MANAGEMENT, LLC - StreetInsider.comForm SC 13G/A Jaguar Health, Inc. Filed by: SABBY MANAGEMENT, LLC - StreetInsider.com
www.streetinsider.com - January 9 at 6:57 PM
Jaguar Health (JAGX) Provides Q4 Commercial Sales Updates - StreetInsider.comJaguar Health (JAGX) Provides Q4 Commercial Sales Updates - StreetInsider.com
www.streetinsider.com - January 9 at 6:57 PM
Jaguar Health Receives First Order for First-Generation of Equilevia, the Companys Non-Prescription, Personalized, Premium Product for Total Gut Health in High-Performance Equine AthletesJaguar Health Receives First Order for First-Generation of Equilevia, the Company's Non-Prescription, Personalized, Premium Product for Total Gut Health in High-Performance Equine Athletes
finance.yahoo.com - January 9 at 6:57 PM
Jaguar Health up 13.4% on 4Q18 commercial sales updatesJaguar Health up 13.4% on 4Q18 commercial sales updates
seekingalpha.com - January 7 at 6:16 PM
Jaguar Health Provides Fourth Quarter 2018 Commercial Sales UpdatesJaguar Health Provides Fourth Quarter 2018 Commercial Sales Updates
finance.yahoo.com - January 7 at 6:16 PM
Jaguar Health, Inc.: Jaguar Health to Present at Biotech Showcase 2019 in San FranciscoJaguar Health, Inc.: Jaguar Health to Present at Biotech Showcase 2019 in San Francisco
www.finanznachrichten.de - January 4 at 8:21 AM
Jaguar Health to Present at Biotech Showcase 2019 in San FranciscoJaguar Health to Present at Biotech Showcase 2019 in San Francisco
finance.yahoo.com - January 4 at 8:21 AM
Jaguar Health up 16% ahead of Q4 reportJaguar Health up 16% ahead of Q4 report
seekingalpha.com - January 2 at 5:26 PM
Jaguar Health to Host Investor Call January 7th at 8 a.m. Eastern to Review 4Q18 PerformanceJaguar Health to Host Investor Call January 7th at 8 a.m. Eastern to Review 4Q'18 Performance
finance.yahoo.com - January 2 at 5:26 PM
Jaguar Health, Inc. Engages T.R. Winston & Company to Advise on Collaboration, Licensing and Development Activities Related to Mytesi and CrofelemerJaguar Health, Inc. Engages T.R. Winston & Company to Advise on Collaboration, Licensing and Development Activities Related to Mytesi and Crofelemer
finance.yahoo.com - December 6 at 5:27 PM
Form NT 10-Q Jaguar Health, Inc. For: Sep 30Form NT 10-Q Jaguar Health, Inc. For: Sep 30
www.streetinsider.com - November 17 at 8:19 AM
Form 8-K Jaguar Health, Inc. For: Nov 14Form 8-K Jaguar Health, Inc. For: Nov 14
www.streetinsider.com - November 17 at 8:19 AM
Jaguar Animal Health, Inc. (JAGX) CEO Lisa Conte on Q3 2018 Results - Earnings Call TranscriptJaguar Animal Health, Inc. (JAGX) CEO Lisa Conte on Q3 2018 Results - Earnings Call Transcript
seekingalpha.com - November 15 at 5:21 PM
Jaguar Health, Inc. Reports Third-Quarter 2018 ResultsJaguar Health, Inc. Reports Third-Quarter 2018 Results
finance.yahoo.com - November 15 at 8:26 AM
Reminder: Jaguar Health, Inc. Will Release 3Q18 Financial Results After Market on November 14thReminder: Jaguar Health, Inc. Will Release 3Q'18 Financial Results After Market on November 14th
finance.yahoo.com - November 13 at 5:08 PM
The Brilliance Behind a Global Operator of Crypto Exchanges BitMax: Understanding the Trans-Fee Mining ModelThe Brilliance Behind a Global Operator of Crypto Exchanges BitMax: Understanding the Trans-Fee Mining Model
finance.yahoo.com - November 7 at 8:06 AM
Form SC 13G Jaguar Health, Inc. Filed by: SABBY MANAGEMENT, LLCForm SC 13G Jaguar Health, Inc. Filed by: SABBY MANAGEMENT, LLC
www.streetinsider.com - November 1 at 5:56 PM
Jaguar Health, Inc. Expects to File Third-Quarter 2018 Financial Results November 14thJaguar Health, Inc. Expects to File Third-Quarter 2018 Financial Results November 14th
finance.yahoo.com - October 29 at 4:58 PM
Jaguar Health, Inc. to Host Investor Meetings at Dawson James Small Cap Growth Conference Tuesday, October 30, 2018 in Jupiter, FloridaJaguar Health, Inc. to Host Investor Meetings at Dawson James Small Cap Growth Conference Tuesday, October 30, 2018 in Jupiter, Florida
finance.yahoo.com - October 24 at 5:04 PM
Jaguar Health Announces Pricing of $9 Million Underwritten Public OfferingJaguar Health Announces Pricing of $9 Million Underwritten Public Offering
finance.yahoo.com - October 2 at 8:25 AM
Key Treatments and Latest Medical Advancements Reshaping Cardiovascular Drugs Market for Increasing GainsKey Treatments and Latest Medical Advancements Reshaping Cardiovascular Drugs Market for Increasing Gains
www.bizjournals.com - September 26 at 5:04 PM
Profit-taking pressures Jaguar Health, down 21%Profit-taking pressures Jaguar Health, down 21%
seekingalpha.com - September 26 at 5:04 PM
These Biotech and Cannabis Stocks Are SkyrocketingThese Biotech and Cannabis Stocks Are Skyrocketing
finance.yahoo.com - September 26 at 5:04 PM
Thinking about buying stock in Advanced Micro Devices, Camber Energy, GoPro, Jaguar Health Inc or Sonic?Thinking about buying stock in Advanced Micro Devices, Camber Energy, GoPro, Jaguar Health Inc or Sonic?
www.prnewswire.com - September 26 at 10:49 AM
Jaguar Health (JAGX) Reports Strategic Partnership with Knight Therapeutics, Offering Exclusive Rights to Commercialize Mytesi in Canada & IsraelJaguar Health (JAGX) Reports Strategic Partnership with Knight Therapeutics, Offering Exclusive Rights to Commercialize Mytesi in Canada & Israel
www.streetinsider.com - September 26 at 8:33 AM
Jaguar Healths stock triples after licensing deal, has been halted 13 times for volatilityJaguar Health's stock triples after licensing deal, has been halted 13 times for volatility
www.marketwatch.com - September 25 at 4:57 PM
Jaguar Health, Inc.: Knight Therapeutics and Jaguar Health Announce Strategic PartnershipJaguar Health, Inc.: Knight Therapeutics and Jaguar Health Announce Strategic Partnership
www.finanznachrichten.de - September 25 at 8:19 AM
Knight Therapeutics and Jaguar Health Announce Strategic PartnershipKnight Therapeutics and Jaguar Health Announce Strategic Partnership
finance.yahoo.com - September 24 at 4:55 PM
Jaguar Health readies equity offering; shares down 2%Jaguar Health readies equity offering; shares down 2%
seekingalpha.com - September 12 at 4:48 PM
Detailed Research: Economic Perspectives on The Michaels Companies, Glu Mobile, Natus Medical, Progenics Pharmaceuticals, QuinStreet, and Jaguar Health — What Drives Growth in Todays Competitive LandscapeDetailed Research: Economic Perspectives on The Michaels Companies, Glu Mobile, Natus Medical, Progenics Pharmaceuticals, QuinStreet, and Jaguar Health — What Drives Growth in Today's Competitive Landscape
finance.yahoo.com - August 27 at 8:31 AM
Form SC 13G Jaguar Health, Inc. Filed by: GLASER JONATHAN MForm SC 13G Jaguar Health, Inc. Filed by: GLASER JONATHAN M
www.streetinsider.com - August 1 at 8:38 AM
RedHill Biopharma Initiates Co-Promotion of HIV/AIDS Anti-Diarrheal Drug Mytesi®RedHill Biopharma Initiates Co-Promotion of HIV/AIDS Anti-Diarrheal Drug Mytesi®
finance.yahoo.com - July 25 at 8:25 AM
New Analysis of Data in Over 21,000 People Living with HIV Shows Diarrhea Continues to be an Issue and Has Not Declined Significantly Over TimeNew Analysis of Data in Over 21,000 People Living with HIV Shows Diarrhea Continues to be an Issue and Has Not Declined Significantly Over Time
finance.yahoo.com - July 24 at 4:43 PM
Napo Pharmaceuticals to Present New Data at the 22nd International AIDS 2018 ConferenceNapo Pharmaceuticals to Present New Data at the 22nd International AIDS 2018 Conference
finance.yahoo.com - July 16 at 4:44 PM
Jaguar Health (JAGX) Reports Q2 Financial UpdatesJaguar Health (JAGX) Reports Q2 Financial Updates
www.streetinsider.com - July 12 at 4:44 PM
Jaguar Animal Health up 22% on Q2 resultsJaguar Animal Health up 22% on Q2 results
seekingalpha.com - July 12 at 4:44 PM
Jaguar Health, Inc. Provides Second Quarter 2018 Financial UpdatesJaguar Health, Inc. Provides Second Quarter 2018 Financial Updates
finance.yahoo.com - July 12 at 4:44 PM
RedHill Biopharma Announces U.S. Co-Promotion Agreement with Napo Pharmaceuticals for HIV/AIDS Anti-Diarrheal Drug Mytesi®RedHill Biopharma Announces U.S. Co-Promotion Agreement with Napo Pharmaceuticals for HIV/AIDS Anti-Diarrheal Drug Mytesi®
finance.yahoo.com - June 28 at 9:07 AM
Jaguar Health (NASDAQ: JAGX) Subsidiary Napo Pharmaceuticals and RedHill Biopharma Enter U.S. Co-Promotion Agreement for Mytesi, Napos FDA-Approved Drug ProductJaguar Health (NASDAQ: JAGX) Subsidiary Napo Pharmaceuticals and RedHill Biopharma Enter U.S. Co-Promotion Agreement for Mytesi, Napo's FDA-Approved Drug Product
finance.yahoo.com - June 28 at 9:07 AM
Jaguar Health, Inc.: Jaguar Health Appoints Pharmaceutical Industry Veteran David MacNaughtan to Board of DirectorsJaguar Health, Inc.: Jaguar Health Appoints Pharmaceutical Industry Veteran David MacNaughtan to Board of Directors
www.finanznachrichten.de - June 20 at 5:52 PM
Jaguar Health Appoints Pharmaceutical Industry Veteran David MacNaughtan to Board of DirectorsJaguar Health Appoints Pharmaceutical Industry Veteran David MacNaughtan to Board of Directors
finance.yahoo.com - June 20 at 5:52 PM
Jaguar Health, Inc.: Jaguar Health Appoints Senior Commercial Pharmaceutical Executive Greg Divis to Board of DirectorsJaguar Health, Inc.: Jaguar Health Appoints Senior Commercial Pharmaceutical Executive Greg Divis to Board of Directors
www.finanznachrichten.de - June 18 at 6:39 PM
Jaguar Health Appoints Senior Commercial Pharmaceutical Executive Greg Divis to Board of DirectorsJaguar Health Appoints Senior Commercial Pharmaceutical Executive Greg Divis to Board of Directors
finance.yahoo.com - June 18 at 9:10 AM
Napo Pharmaceuticals Presents New Data at the 13th International Conference on HIV Treatment and Prevention Adherence Regarding the Use of Mytesi (Crofelemer) to Treat Noninfectious Diarrhea in HIV PatientsNapo Pharmaceuticals Presents New Data at the 13th International Conference on HIV Treatment and Prevention Adherence Regarding the Use of Mytesi (Crofelemer) to Treat Noninfectious Diarrhea in HIV Patients
finance.yahoo.com - June 12 at 5:00 PM
Is Jaguar Health Inc’s (NASDAQ:JAGX) Balance Sheet Strong Enough To Weather A Storm?Is Jaguar Health Inc’s (NASDAQ:JAGX) Balance Sheet Strong Enough To Weather A Storm?
finance.yahoo.com - June 3 at 7:18 PM
Jaguar Animal Health (JAGX) Effected 1-for-15 Reverse Stock SplitJaguar Animal Health (JAGX) Effected 1-for-15 Reverse Stock Split
www.streetinsider.com - June 1 at 5:34 PM
This page was last updated on 2/18/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel